Jo Dong Hyun, Kim Seong-Joon, Chae Jong Hee, Yu Young Suk
Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
Korean J Ophthalmol. 2011 Apr;25(2):116-20. doi: 10.3341/kjo.2011.25.2.116. Epub 2011 Mar 11.
To study the clinical characteristics of optic neuritis in Korean children.
A retrospective review of the medical charts of 20 patients who were diagnosed with optic neuritis before age 10 was conducted in this study. Data were collected on the demographics, clinical features, use of intravenous corticosteroids, neuroimaging, and diagnosis of multiple sclerosis.
The mean age at diagnosis was 6.5 ± 1.8 years (range, 3 to 9 years). Seventeen patients (85%) were female, and 13 patients (65%) exhibited bilateral diseases. Visual acuity had decreased to ≤20 / 200 in 16 of the 20 patients, and recovered to ≥20 / 40 in 16 of the 20 patients. The mean duration between the worst visual acuity and 20 / 40 was 2.30 ± 2.91 months. Intravenous corticosteroid treatment was performed in 15 patients and exerted a beneficial effect on the visual outcomes. Disc swelling was observed in 75.8% of the affected eyes. Multiple sclerosis was diagnosed in five patients with a mean follow-up period of 21.9 ± 20.3 months. The presence of lesions in brain magnetic resonance images was identified as the most significant factor with regards to the occurrence of multiple sclerosis.
In children with optic neuritis, a profound decrease in initial visual acuity and rapid recovery of visual acuity were confirmed. Corticosteroid treatment resulted in a beneficial effect on visual outcomes, but had no effect on the risk of multiple sclerosis.
研究韩国儿童视神经炎的临床特征。
本研究对10岁前被诊断为视神经炎的20例患者的病历进行了回顾性分析。收集了人口统计学、临床特征、静脉注射皮质类固醇的使用情况、神经影像学以及多发性硬化症诊断等数据。
诊断时的平均年龄为6.5±1.8岁(范围3至9岁)。17例患者(85%)为女性,13例患者(65%)表现为双侧疾病。20例患者中有16例视力下降至≤20/200,20例患者中有16例视力恢复至≥20/40。最差视力与20/40之间的平均持续时间为2.30±2.91个月。15例患者接受了静脉注射皮质类固醇治疗,对视力预后产生了有益影响。75.8%的患眼观察到视盘肿胀。5例患者被诊断为多发性硬化症,平均随访期为21.9±20.3个月。脑磁共振图像中病变的存在被确定为与多发性硬化症发生相关的最显著因素。
在视神经炎患儿中,证实了初始视力显著下降和视力快速恢复。皮质类固醇治疗对视功能预后有有益影响,但对多发性硬化症的风险没有影响。